Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 899-904

  Fischer, Joshua L ^a   Lancia, Jody K ^a   Mathur, Anita ^a   Smith, Martin L ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer chemoprevention; DNA repair; Nucleotide excision repair; Redox factor 1

Indexed keywords

BRCA1 PROTEIN; PROTEIN P53; RECOMBINANT PROTEIN; REDOX EFFECTOR FACTOR 1; SELENIUM;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNODETECTION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; ULTRAVIOLET RADIATION;

ANIMALS; BRCA1 PROTEIN; CELL LINE, TUMOR; COLONIC NEOPLASMS; DNA DAMAGE; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; HUMANS; LUNG NEOPLASMS; MICE; SELENOMETHIONINE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33645809586     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Adimoolam S and Ford JM: p53 and DNA damage-inducible expression of the xeroderma pigmentosum XPC gene. Proc Natl Acad Sci USA 99: 12985-12990, 2002.
2. El-Deiry WS: Transactivation of DNA repair genes by BRCA1. Cancer Biol Ther 1: 490-491, 2002.
3. Pluquet O and Hainaut P: Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett 174: 1-15, 2001.
4. Seo YR, Kelley MR and Smith ML: Selenomethionine regulation of p53 by a Ref1-dependent redox mechanism. Proc Natl Acad Sci USA 99: 14548-14553, 2002.
5. Hanson S, Kim E and Deppert W: Redox factor-1 (Ref1) enhances specific p53 binding of p53 by promoting p53 tetramerization. Oncogene 24: 1641-1647, 2005.
6. Seo YR, Sweeney C and Smith ML: Selenomethionine induction of a DNA repair response in human fibroblasts. Oncogene 21: 3663-3669, 2002.
7. Smith ML, Lancia JK, Mercer TI and Ip C: Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res 24: 1401-1408, 2004.
8. Kovalsky O, Lung FDT, Roller PP and Fornace AJ Jr: Oligomerization of human Gadd45a protein. J Biol Chem 276: 39330-39339, 2001.
9. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S and Prives C: Identification of redox/repair protein Ref1 as a potent activator of p53. Genes Dev 11: 558-570, 1997.
10. Reid ME, Stratton MS, Lillico AJ, Fakih M, Natarajan R, Clark LC and Marshall JR: A report of high-dose slenium supplementation: response and toxicities. J Trace Elem Med Biol 18: 69-74, 2004.
11. Patrick L: Selenium biochemistry and cancer: a review of the literature. Altern Med Rev 9: 239-258, 2004.
12. Wu HH and Momand J: Pyrrolidine dithiocarbamate prevents p53 activation and promotes p53 cysteine residue oxidation. J Biol Chem 273: 18898-18905, 1998.
13. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B: Definition of a consensus binding site for p53. Nat Genet J: 45-49, 1992.
14. Keller DM, Zeng SX and Lu H: Interaction of p53 with cellular proteins. Methods Mol Biol 234: 121-133, 2003.
15. Takimoto R, MacLachlan TK, Dicker Dt, Niitsu Y, Mori T and El-Deiry WS: Brcal transcriptionally regulates damaged DNA binding protein DDB2 in the DNA repair response following UV-irradiation. Cancer Biol Ther 1: 177-186, 2002.
16. Seemann S and Hainaut P: Roles of thioredoxin reductase 1 and APE/Ref 1 in the control of basal p53 stability and activity. Oncogene 24: 3853-3863, 2005.
17. Redman C, Scott JA, Baines AT, Basye JL, Clark LC, Calley C, Roe D, Payne CM and Nelson MA: Cancer Lett 125: 103-110, 1995.
18. Hartman AR and Ford JM: BRCA1 and p53: compensatory roles in DNA repair. J Mol Med 81: 700-707, 2003.
19. Scully R, Xie A and Nagaraju G: Molecular functions of Brca1 in the DNA damage response. Cancer Biol Ther 3: 521-527, 2004.
20. Bhattacharyya A, Ear US, Koller BH, Weichselbaum RR and Bishop DK: The breast cancer susceptibility gene Brcal is required for subnuclear assembly of Rad51 and survival following treatment with cisplatin. J Biol Chem 275: 23899-23903, 2000.
21. Yun J, Zhong O, Kwak JY and Lee WH: Hypersensitivity of Brcal-deficient MEF to the interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest. Oncogene 24: 4009-4016, 2005.
22. Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, Henning W, Pedeux R, Wang XW, Hofseth LJ, Yang O, Garfield SH, Sturzbecher HW and Harris CC: p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res 63: 2596-2605, 2003.
23. Kumari A, Schultz N and Helleday T: p53 protects from replication-associated DNA dounle-strand breaks in mammalian cells. Oncogene 23: 2324-2329, 2004.
24. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC and Ashworth A: Targeting the DNA repair defect in Brca1 mutant cells as a therapeutic strategy. Nature 434: 917-921, 2005.
25. Amundson SA, Patterson A, Do KT and Fornace AJ Jr: A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol Ther 1: 145-149, 2002.
26. Smith ML and Fornace AJ Jr: P53-mediated protective responses to UV-radiation. Proc Natl Acad Sci USA 94: 12255-12257, 1997.
27. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR, Deng CX, Hanawalt PC and Fornace AJ Jr: p53-mediated DNA repair responses to UV-radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol Cell Biol 20: 3705-3714, 2000.